The revenue your practice is leaving on the table, quantified.
Adjust the inputs below to model the financial impact of moving your revenue cycle from industry-median to top-quartile performance. All calculations are based on MGMA and HFMA benchmarks.
Tell us about your current state
What Medusind could recover
How we calculate this
Transparent math. No black boxes. Audit-ready for your CFO.
Annual Revenue Uplift (the recurring number)
The core formula is simple and transparent:
Collectible Charges × (Target NCR − Your Current NCR)
Where:
- Collectible Charges = Gross Charges × (1 − Contractual Adjustment %)
- Gross Charges = Providers × specialty-average charges per provider (adjustable in Advanced)
- Target NCR = 98% — the average of Medusind's active client book, consistent with MGMA top-quartile performance. Your Current NCR is the slider value.
This is a conservative approach: it assumes no increase in charge capture, no payor contract renegotiation, and no improvement in patient collections — all of which typically add to the uplift.
Cash Released from A/R (the one-time number)
Bringing Days in A/R from your current level down to the Medusind target (~32 days) releases working capital that was previously tied up in unpaid claims.
(Current A/R Balance) − (Optimized A/R Balance)
Where A/R Balance = (Annualized Collections ÷ 365) × Days in A/R.
This is a one-time gain — the balance sheet improvement from accelerating collections. After that, your faster cash cycle is a permanent operational advantage.
Benchmarks & sources
- MGMA Net Collection Rate benchmark: 95% (multi-specialty median); 98% top-quartile for groups of 20+ providers
- MGMA Days in A/R benchmark: < 40 days; top performers under 30
- Industry denial rate: 10–12% trending upward (2025 MGMA data); best-in-class under 5%
- A/R > 90 days benchmark: MGMA range 12–15% of total A/R
- Medusind client average: 98%+ NCR, 30% improvement in patient collections, 20% A/R improvement (based on active book of business)
Sources: MGMA DataDive 2024–2025, HFMA MAP Keys, Medusind client portfolio metrics.
What's NOT included (conservative framing)
We deliberately exclude several real sources of value to keep this model defensible:
- Clean claim rate improvements that reduce re-work hours
- Staff cost avoidance from eliminating in-house billing FTE
- Patient collection improvements (our clients typically see ~30% lift here)
- Coding optimization that increases charge capture per encounter
- Credentialing acceleration that reduces provider ramp time to first claim
We'll model these in a working session tailored to your practice.
What we'd need from you to refine this
- 12 months of charges, adjustments, and collections by payor
- Current A/R aging buckets (0–30, 31–60, 61–90, 91+)
- Denial volume and top denial reason codes
- Payor mix percentages
- Your current PMS/EHR (Medusind supports 70+ systems — no migration required)
This is exactly what we'll cover in the working session.